(VIANEWS) – Eton Pharmaceuticals (ETON), First Bank (FRBA), Peoples Bancorp (PEBO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eton Pharmaceuticals (ETON)
56.5% sales growth and 15.9% return on equity
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Earnings Per Share
As for profitability, Eton Pharmaceuticals has a trailing twelve months EPS of $0.09.
PE Ratio
Eton Pharmaceuticals has a trailing twelve months price to earnings ratio of 48.67. Meaning, the purchaser of the share is investing $48.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 200% and positive 80% for the next.
Yearly Top and Bottom Value
Eton Pharmaceuticals’s stock is valued at $4.38 at 19:22 EST, way below its 52-week high of $5.81 and way higher than its 52-week low of $2.42.
2. First Bank (FRBA)
27.8% sales growth and 6.74% return on equity
First Bank provides various banking products and services to individuals, businesses, and governmental entities. The company accepts various deposits, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. Its loan products include commercial and industrial loans; commercial real estate loans, such as owner-occupied, investor, construction and development, and multi-family loans; residential real estate loans comprising residential mortgages, first and second lien home equity loans, and revolving lines of credit; and consumer and other loans that include auto, personal, and traditional installment loans. The company also provides electronic banking services, including Internet and mobile banking, electronic bill payment, and banking by phone, as well as ATM and debit cards, and wire and ACH transfer services; remote deposit capture; and cash management services. As of December 31, 2021, it operated 18 full-service branches in Cinnaminson, Cranbury, Delanco, Denville, Ewing, Flemington, Hamilton, Hamilton, Lawrence, Mercerville, Pennington, Randolph, Somerset, and Williamstown counties in New Jersey, as well as Doylestown, Trevose, Warminster, and West Chester counties in Pennsylvania. First Bank was incorporated in 2007 and is headquartered in Hamilton, New Jersey.
Earnings Per Share
As for profitability, First Bank has a trailing twelve months EPS of $1.05.
PE Ratio
First Bank has a trailing twelve months price to earnings ratio of 14.17. Meaning, the purchaser of the share is investing $14.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.74%.
3. Peoples Bancorp (PEBO)
24.6% sales growth and 12.13% return on equity
Peoples Bancorp Inc. operates as the holding company for Peoples Bank that provides commercial and retail banking products and services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and provides commercial and industrial, commercial real estate, construction, finance, residential real estate, and consumer indirect and direct loans, as well as home equity lines of credit and overdrafts. It also offers debit and automated teller machine (ATM) cards; safe deposit rental facilities; money orders and cashier's checks; and telephone, mobile, and Internet-based banking services. In addition, the company provides various life, health, and property and casualty insurance products; third-party insurance administration; insurance premium financing; commercial and technology equipment leasing; fiduciary and trust; underwriting, origination and servicing of equipment leases, and equipment financing agreements; and asset management and administration services, as well as employee benefit, retirement, and health care plan administration services. Further, it offers brokerage services through an unaffiliated registered broker-dealers; insurance premium finance lending and lease financing services; and credit cards to individuals and businesses, as well as provides merchant credit card transaction processing, and person-to-person payment processing services. The company operates through 135 financial service offices and ATMs, including 119 full-service branches in Ohio, West Virginia, Kentucky, Virginia, Washington, D.C., and Maryland. Peoples Bancorp Inc. was founded in 1902 and is based in Marietta, Ohio.
Earnings Per Share
As for profitability, Peoples Bancorp has a trailing twelve months EPS of $3.42.
PE Ratio
Peoples Bancorp has a trailing twelve months price to earnings ratio of 10.09. Meaning, the purchaser of the share is investing $10.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.13%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31.3%, now sitting on 387.49M for the twelve trailing months.
Yearly Top and Bottom Value
Peoples Bancorp’s stock is valued at $34.52 at 19:22 EST, under its 52-week high of $34.85 and way above its 52-week low of $23.05.
4. Exelixis (EXEL)
18.4% sales growth and 3.8% return on equity
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.
Earnings Per Share
As for profitability, Exelixis has a trailing twelve months EPS of $0.29.
PE Ratio
Exelixis has a trailing twelve months price to earnings ratio of 82.55. Meaning, the purchaser of the share is investing $82.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 1.77B for the twelve trailing months.
Previous days news about Exelixis(EXEL)
- Exelixis (exel) posts preliminary 2023 results, to cut 13% jobs. According to Zacks on Monday, 8 January, "For 2024, Exelixis expects revenues to be between $1.825 billion and $1.925 billion, while product revenues are projected to be in the $1.65-$1.75 billion range. ", "This year, Exelixis is focused on advancing JEWEL-101, the phase I study of XB002 alone and in combination with immunotherapy in a variety of solid tumor settings, with the goal of prioritizing sensitive tumor types for full development."
5. Ship Finance International Limited (SFL)
17% sales growth and 9.56% return on equity
SFL Corporation Ltd., a maritime and offshore asset owning and chartering company, engages in the ownership, operation, and chartering out of vessels and offshore related assets on medium and long-term charters. The company is also involved in the charter, purchase, and sale of assets. In addition, it operates in various sectors of the maritime, and shipping and offshore industries, including oil, chemical, oil product, container, and car transportation, as well as dry bulk shipments and drilling rigs. As of December 31, 2021, the company owned six crude oil tankers, 15 dry bulk carriers, 35 container vessels, two car carriers, one jack-up drilling rig, one ultra-deepwater drilling unit, two chemical tankers, and four oil product tankers. It primarily operates in Bermuda, Cyprus, Liberia, Norway, Singapore, the United Kingdom, and the Marshall Islands. The company was formerly known as Ship Finance International Limited and changed its name to SFL Corporation Ltd. in September 2019. SFL Corporation Ltd. was incorporated in 2003 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Ship Finance International Limited has a trailing twelve months EPS of $0.78.
PE Ratio
Ship Finance International Limited has a trailing twelve months price to earnings ratio of 15.01. Meaning, the purchaser of the share is investing $15.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.56%.
6. Credicorp Ltd. (BAP)
6.6% sales growth and 17.21% return on equity
Credicorp Ltd., a financial services holding company, provides various financial, insurance, and health services and products primarily in Peru and internationally. The company's Universal Banking segment offers deposits and current accounts, and various credits and financial instruments to individuals and legal entities. Its Insurance and Pensions segment issues insurance policies to cover losses in commercial property, transportation, marine vessels, automobile, life, health, and pensions, as well as provides private pension fund management services. The company's Microfinance segment manages loans, credits, deposits, and current accounts of the small and microenterprises. Its Investment Banking and Wealth Management segment offers its services to corporations, institutional investors, governments, and foundations; engages in structuring and placement of issues in the primary market, as well as the execution and negotiation of operations in the secondary market; and structures securitization processes for corporate customers and manages mutual funds. The company was founded in 1889 and is headquartered in Lima, Peru.
Earnings Per Share
As for profitability, Credicorp Ltd. has a trailing twelve months EPS of $16.68.
PE Ratio
Credicorp Ltd. has a trailing twelve months price to earnings ratio of 8.75. Meaning, the purchaser of the share is investing $8.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.21%.
7. WillScot Mobile Mini Holdings Corp. (WSC)
6% sales growth and 23.68% return on equity
WillScot Mobile Mini Holdings Corp. provides modular space and portable storage solutions in the United States, Canada, Mexico, and the United Kingdom. The company leases various office space and storage solutions for temporary applications across a customer base in the commercial and industrial, construction, retail, education, health care, government, transportation, security, and energy sectors. . It operates a fleet of over 350,000 portable offices and storage containers. The company is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, WillScot Mobile Mini Holdings Corp. has a trailing twelve months EPS of $1.71.
PE Ratio
WillScot Mobile Mini Holdings Corp. has a trailing twelve months price to earnings ratio of 24.8. Meaning, the purchaser of the share is investing $24.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.68%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 30% and 30.6%, respectively.
Yearly Top and Bottom Value
WillScot Mobile Mini Holdings Corp.’s stock is valued at $42.40 at 19:22 EST, way below its 52-week high of $53.46 and way above its 52-week low of $34.40.
8. OFG Bancorp (OFG)
5.5% sales growth and 17.39% return on equity
OFG Bancorp, a financial holding company, provides a range of banking and financial services. It operates through three segments: Banking, Wealth Management, and Treasury. The company offers checking and savings accounts, as well as time deposit products; commercial, consumer, auto leasing, and mortgage lending services; financial planning and insurance services; and corporate and individual trust, and retirement services. In addition, it provides securities brokerage and investment advisory services, including various investment alternatives, such as tax-advantaged fixed income securities, mutual funds, stocks, and bonds to retail and institutional clients; and separately-managed accounts and mutual fund asset allocation programs. Further, the company engages in the insurance agency and reinsurance businesses; administration and servicing of retirement plans; various treasury-related functions with an investment portfolio consisting of mortgage-backed securities, obligations of U.S. government sponsored agencies, and U.S. Treasury securities and money market instruments; and management and participation in public offerings and private placements of debt and equity securities. Additionally, it offers money management and investment banking services; and engages in the asset/liability management activities, such as purchases and sales of investment securities, interest rate risk management, derivatives, and borrowings. OFG Bancorp was founded in 1964 and is headquartered in San Juan, Puerto Rico.
Earnings Per Share
As for profitability, OFG Bancorp has a trailing twelve months EPS of $3.81.
PE Ratio
OFG Bancorp has a trailing twelve months price to earnings ratio of 9.85. Meaning, the purchaser of the share is investing $9.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.39%.
Volume
Today’s last reported volume for OFG Bancorp is 144176 which is 30.67% below its average volume of 207985.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4%, now sitting on 625.86M for the twelve trailing months.
